Semaglutide
GLP-1 receptor agonist analog used as a reference standard in incretin-pathway research.
Unit Price
$85.00
- Latest Lot
- RQ-SEM-2406
- Availability
- In stock
Technical Specifications
Storage & Handling
Store lyophilized at -20°C, protected from light.
Reconstitute in a sterile setting. Aliquot to limit freeze-thaw cycles.
Overview
Semaglutide is a long-acting GLP-1 receptor agonist analog frequently used as a reference standard in metabolic and incretin-signaling research. Supplied lyophilized for reconstitution.
Research Context
Employed in preclinical research examining GLP-1 receptor signaling and metabolic-pathway endpoints. For laboratory research use only.
Certificates of Analysis
RQ-SEM-2406
Janoshik Analytical · 2025-12-05 · 99.6%
All materials are sold strictly for laboratory and research use only. Not for human or veterinary consumption.
Related Compounds
Tirzepatide
5 mg lyophilized vialDual GIP / GLP-1 receptor agonist reference compound for incretin co-agonism research.
- Formula
- C225H348N48O68
- CAS
- 2023788-19-2
- Mol. Weight
- 4813.45 g/mol
- Purity
- ≥ 99%
Retatrutide
5 mg lyophilized vialTriple GIP / GLP-1 / glucagon receptor agonist reference peptide for metabolic research.
- Formula
- C221H342N46O68
- CAS
- 2381089-83-2
- Mol. Weight
- 4731.32 g/mol
- Purity
- ≥ 99%
BPC-157
10 mg lyophilized vialSynthetic pentadecapeptide widely used as a reference compound in tissue-repair research models.
- Formula
- C62H98N16O22
- CAS
- 137525-51-0
- Mol. Weight
- 1419.53 g/mol
- Purity
- ≥ 99%